TD

Tarakkumar Doshi

Active Director Director DIN 06424369
DIN 06424369 First appointment Nov 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2012
Shareholding value •••• Premium profile

About Tarakkumar Doshi

Data last updated:

Tarakkumar Doshi is a Director at Alaunus Pharmaceutical Private Limited (since 2012). The company operates in Pharma. Alaunus Pharmaceutical Private Limited reported revenue of ₹3.2 Lakh (FY 2017).

DIN 06424369
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2012
Oldest Company Age 13 yrs
Largest company Alaunus Pharmaceutical Private Limited · ₹3.2 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20122012₹3.2 Lakh (FY 2017)Active

Board colleagues of Tarakkumar Doshi

Directorship timeline

Open interactive timeline →
Alaunus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Tarakkumar Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tarakkumar Doshi

Tarakkumar Doshi currently holds 1 directorship: Alaunus Pharmaceutical Private Limited (Director, since 21 Nov 2012, revenue ₹3.2 Lakh (FY 2017)).

Tarakkumar Doshi was first appointed on 21 Nov 2012 as Director at Alaunus Pharmaceutical Private Limited.

The current boards of Tarakkumar Doshi's companies include Chaxuben Tarakbhai Doshi (Alaunus Pharmaceutical Private Limited), Doshi Kaushalkumar (Alaunus Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available